Results 51 to 60 of about 14,960 (189)

The association between parental migraine, infantile colic, and later migraine in childhood: A scoping review of current evidence

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Background Evidence suggests that infantile colic, a common condition in early infancy, shares pathophysiological features with migraine. Objective Aim was to examine the current evidence on the association between infantile colic and migraine, focusing on both maternal migraine as a risk factor for infantile colic and infantile colic as a ...
Bella Poutanen, Ilari Kuitunen
wiley   +1 more source

Causal association between systemic lupus erythematosus and the risk of migraine: A Mendelian randomization study

Brain and Behavior
Background Numerous studies have found that patients with systemic lupus erythematosus (SLE) often have comorbid headache, especially migraine. However, the causal relationship between genetically determined SLE and migraine risk remains unclear ...
Meixuan Ren, Hangtian Yu, Bing Xiao, Yan Zhao, Jiewei Yan, Jianghong Liu   +5 more
doaj   +1 more source

Arterial spin labeling MRI applied to migraine: current insights and future perspectives

The Journal of Headache and Pain, 2023
Introduction Advanced neuroimaging techniques have extensively contributed to elucidate the complex mechanisms underpinning the pathophysiology of migraine, a neurovascular disorder characterized by episodes of headache associated with a constellation of
Antonio Russo, Marcello Silvestro, Alessandro Tessitore, Ilaria Orologio, Alessandro Pasquale De Rosa, Rosa De Micco, Gioacchino Tedeschi, Fabrizio Esposito, Mario Cirillo   +8 more
doaj   +1 more source

EEG reveals what the eyes can't see: A clinical vignette of epileptic visual loss

Epileptic Disorders, EarlyView.
Zoi Kallia, Vasiliki Poulidou, Evripidis Pityrigkas, Panteleimon Ioannidis, Martha Spilioti, Vasilios K. Kimiskidis   +5 more
wiley   +1 more source

Plasma amylin levels in migraine and after erenumab treatment: A REFORM study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Researchers are searching for blood tests that can show what is happening in migraine and help predict who will benefit from preventive treatment, and blood amylin (a signaling molecule known to trigger migraine) has been shown to be elevated in people with chronic migraine.
Rogelio Domínguez‐Moreno, Tyla I. Alexander, William K. Karlsson, Haidar M. Al‐Khazali, Michael L. Garelja, Rune H. Christensen, Messoud Ashina, Debbie L. Hay, Håkan Ashina   +8 more
wiley   +1 more source

Novel targets in headache: A narrative review

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This narrative review summarizes novel applications for the use of calcitonin gene‐related peptide (CGRP)‐targeted therapies that go beyond migraine, the latest updates with respect to targeting pituitary adenylate cyclase‐activating peptide (PACAP) as therapeutic in migraine, as well as exploring other more recently ...
Adriana Della Pietra, Peter J. Goadsby, Carolina Oldoni, Stephen Silberstein, Fred Cohen, Simon Akerman   +5 more
wiley   +1 more source

Perceived headache responses to exercise in patients with migraine: A cross‐sectional study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To characterize patient‐perceived headache responses to exercise in migraine and to identify associated clinical factors using a large‐scale registry. Background Regular exercise is often recommended for patients with migraine; however, it can also trigger migraine attacks.
Young‐Eun Gil, Mi Ji Lee
wiley   +1 more source

Pregnancy outcomes following exposure to galcanezumab: Analysis of cases from the galcanezumab clinical trials and postmarketing database

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study was conducted to describe pregnancy outcomes reported following maternal or paternal exposure to galcanezumab in clinical trials and postmarketing surveillance. Background Galcanezumab is a calcitonin gene‐related peptide‐inhibiting monoclonal antibody indicated for the preventive treatment of migraine.
Irene Boz, Jan Lewis Brandes, Christopher Robinson, Maria Fernanda Scantamburlo Fernandes, Sarah Lipsius, LaRonda Morford, Enemona Emmanuel Adaji, Anaclara Prada Jardim, Holland C. Detke   +8 more
wiley   +1 more source

Visual migraine aura with or without headache: association with right to left shunt and assessment following transcutaneous closure

Clinical Ophthalmology, 2012
M Khalid Mojadidi,1 Hamidreza Khessali,1 Rubine Gevorgyan,1 Ralph D Levinson,2 Jonathan M Tobis11Division of Interventional Cardiology, David Geffen School of Medicine, University of California at Los Angeles, 2Division of Comprehensive Ophthalmology and
Mojadidi MK, Khessali H, Gevorgyan R, Levinson RD, Tobis JM   +4 more
doaj  

Is migraine a common manifestation of CADASIL-Cons

The Journal of Headache and Pain
Headaches and transient neurological symptoms that bear resemblances to clinical manifestations of migraine, especially migraine with aura, are common among patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and ...
Yen-Feng Wang
doaj   +1 more source